| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076754 Substituted spiroheterocycles |
| 03/27/2008 | US20080076753 Substituted spiroheterocycles |
| 03/27/2008 | US20080076744 Method for treating inflammatory conditions with progesterone or progesterone analogs |
| 03/27/2008 | US20080076733 novel synthetic thiolatocobalamin; protects animal cells against oxidative stress damage; dietary supplement; also with vitamin B6 and a folate; cardiovascular disease, cerebrovascular disease, peripheral vascular disease, glaucoma, Alzheimer's disease, and dementia |
| 03/27/2008 | US20080076730 Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy |
| 03/27/2008 | US20080076718 oligopeptide or polypeptide amino acid sequences as biodrug antitumor agents, anticarcinogenic agents; treating autoimmune diseases, AIDS, inflammatory diseases, cardiovascular disorder of ischemic processes, allograft rejection, cerebral strokes, traumas, burns, Alzheimer's disease, Parkinson's disease |
| 03/27/2008 | US20080076712 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/27/2008 | US20080076148 Using presence hyaluronic acid on surface of cell as evaluative tool in screening for preferential progenitor cells |
| 03/27/2008 | US20080075764 Synthetic and semi-synthetic three-dimensional bodies, such as liposomes, which antiinflammatory, organ protective and immune regulatory effects; autoimmune diseases |
| 03/27/2008 | US20080075762 Compositions for delivery of drug combinations |
| 03/27/2008 | US20080075750 Methods for producing three-dimensional tissue-engineered cardiac constructs and uses regarding same |
| 03/27/2008 | US20080075716 purified and/or genetic engineered antibodies or fragments comprises variable heavy or light chain peptides capable of binding oxidized fragments of alipoproteins, used as vaccines against cardiovascular disorders |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075666 Methods and compositions for treating diastolic dysfunction |
| 03/27/2008 | DE102006046410A1 Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von ischämischen Krankheiten Drugs for the prophylaxis or treatment or diagnosis of ischemic diseases |
| 03/27/2008 | DE102006042436A1 Kaugummizubereitungen mit physiologischen Wirkstoffen Chewing gum compositions with physiologically active agents |
| 03/27/2008 | DE102006042143A1 Neue substituierte Bipyridin-Derivate und ihre Verwendung New substituted bipyridine derivatives and their use |
| 03/27/2008 | CA2665851A1 Spiro benzazepines as vasopressin antagonists |
| 03/27/2008 | CA2665849A1 Spiro benzazepines used as vasopressin antagonists |
| 03/27/2008 | CA2664335A1 Rho kinase inhibitors |
| 03/27/2008 | CA2663547A1 Method of treating endothelial dysfunction |
| 03/27/2008 | CA2663269A1 Combination of nmda-receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | CA2663263A1 Renin inhibitors |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903043A1 Novel pharmaceutical |
| 03/26/2008 | EP1902733A1 Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1902722A1 Agent for elevating adiponectin concentration |
| 03/26/2008 | EP1902717A2 Vasopressin antagonist and oxytocin antagonist |
| 03/26/2008 | EP1902710A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 03/26/2008 | EP1902709A1 Extended release indapamide tablets and their process of manufacture |
| 03/26/2008 | EP1902316A2 Method of treating human volume expansion mediated hypertension employing resibufogenin |
| 03/26/2008 | EP1902314A1 Method for evaluating the effects of smoke on bronchioles |
| 03/26/2008 | EP1902141A1 Adamts13-comprising compositions having thrombolytic activity |
| 03/26/2008 | EP1902057A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 03/26/2008 | EP1902039A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 03/26/2008 | EP1902032A1 Pharmaceutical compounds |
| 03/26/2008 | EP1901771A2 Nattokinase for reducing whole blood viscosity |
| 03/26/2008 | EP1901764A1 Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| 03/26/2008 | EP1901739A2 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 03/26/2008 | EP1901730A1 Use of soluble guanylate cyclase activators for treating reperfusion damage |
| 03/26/2008 | EP1901712A2 Therapeutic sclerosing foam made preferably xenon |
| 03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/26/2008 | EP1673107B1 Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker |
| 03/26/2008 | EP1610811A4 Prevention and treatment of cardiac arrhythmias |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP0923553B1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl compounds |
| 03/26/2008 | CN101151263A Substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151252A Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 03/26/2008 | CN101151247A 3,4,5-substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
| 03/26/2008 | CN101151031A Tricyclic cytoprotective compounds |
| 03/26/2008 | CN101151027A Combination of organic compounds |
| 03/26/2008 | CN101148642A Probiotic/non-probiotic combinations |
| 03/26/2008 | CN101148459A High-purity scutellarin salt and slow release preparation |
| 03/26/2008 | CN101147806A Berberine intestinal controlled-releasing microcapsule and its preparation method |
| 03/26/2008 | CN101147787A Red glossy ganoderma Chinese medicinal herb composition |
| 03/26/2008 | CN101147780A Medicine for treating hypertension and hyperlipemia and its preparing process |
| 03/26/2008 | CN101147760A Externally-applied medicine for treating hemorrhoid |
| 03/26/2008 | CN101147754A Compound effervescence preparation containing pureraria root extraction |
| 03/26/2008 | CN101147742A Medicinal composition containing licorice total flavone and alooerine |
| 03/26/2008 | CN100376597C Polypeptide for decreasing blood pressure, its separation method and uses |
| 03/26/2008 | CN100376596C Buxine, buxine hydrochloride, and its preparing method and formulation |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
| 03/26/2008 | CN100376273C Soft capsule for treating heart palpitation and its preparation method |
| 03/26/2008 | CN100376267C Pharmaceutical formulation consisting of plant extract with calcium coating |
| 03/26/2008 | CN100376257C A medicine for treating coronary atherosclerotic heart disease |
| 03/26/2008 | CN100376255C Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatary activity and anti-atherogenic activity |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348412 Ouabain-specific monoclonal antibodies |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348155 Method for identifying compounds for treating aging processes in the coronary circulatory system |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7347998 Method of delivering therapeutic agents to site of tissue injury |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2432432C Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |